Ignite Creation Date:
2025-12-25 @ 1:14 AM
Ignite Modification Date:
2026-01-03 @ 7:19 PM
Study NCT ID:
NCT04401293
Status:
COMPLETED
Last Update Posted:
2021-11-22
First Post:
2020-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
Sponsor:
Northwell Health
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
20-0340
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None